Target intelligence / Profile preview

Hollow fiber membrane for blood purification

Molecular classification
Other
01

Overview

Hollow fiber membranes are synthetic filtration devices made from polymers such as poly(vinyl alcohol), ethylene-vinyl alcohol copolymer, polyimide, and others. They consist of bundles of capillary-like tubules with semi-permeable microporous walls that separate blood flowing inside the tube (lumen) from dialysate or filtering fluid outside (shell). By controlling membrane composition and pore size, these devices allow selective removal of water, ions, and low-to-medium molecular weight solutes (e.g., urea, creatinine), while retaining larger proteins and cells. Hollow fiber dialyzers are essential for hemodialysis and plasmapheresis, with applications in renal failure, plasma exchange, and extracorporeal oxygenation. Their performance depends on blood compatibility, fouling resistance, selectivity, and mechanical properties. There is no specific molecular target here; instead, these membranes play a critical role as medical devices in extracorporeal blood treatment. They do not fall under the typical categories used in drug discovery or pharmacology for molecular targets.

Other names
Hollow fiber dialyzerhollow fiber ultrafiltration membranehemofiltermembrane dialyzer
02

Mechanism of action

Physical removal of solutes and water by filtration through selectively permeable synthetic membranes. Size-selective permeation based on molecular weight cutoff determined by pore size and membrane material.

03

Biological functions

Blood purificationSolute and fluid removal from bloodSeparation of plasma or blood componentsDialysis and hemofiltration processes
04

Disease associations

Chronic renal failure (hemodialysis)Acute kidney injuryPlasma exchange (autoimmune, neurological disorders)Other disorders requiring extracorporeal blood purification
05

Safety considerations

Risk of infectionThrombosis and clotting of blood within membraneMembrane biocompatibility and immune activation (complement, platelet activation)Possible protein loss, serum leakage, and inefficiency due to membrane fouling or clogging
06

Interacting drugs

Anticoagulants (e.g., heparin)
07

Biomarkers

Blood urea nitrogen (BUN)CreatinineElectrolytesAlbumin

Beyond the preview

Go deeper on Hollow fiber membrane for blood purification.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hollow fiber membrane for blood purification.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call